Cagrilintide Dosing Direct answer: cagrilintide is dosed once weekly and titrated upward over roughly 1620 weeks, with 2.4 mg being the highest dose studied (the dose used in the CagriSema program)
Side effects can overlap, especially digestive symptoms and low intake
Practically, BPC-157's gut-healing properties may help counteract the severe nausea often caused by GLP-1s, and its tissue-protective effects may help mitigate the muscle loss associated with rapid weight reduction
These include individuals with a personal or family history of medullary thyroid carcinoma, those diagnosed with multiple endocrine neoplasia syndrome type 2, patients with severe gastrointestinal conditions such as gastroparesis, individuals who are pregnant or breastfeeding, and patients with severe renal impairment
Genetic testing is used to see if a person has the genetic variants that cause cvEDS